secwatch.observer — SEC 8-K summary
======================================

Issuer:     Peak Bio, Inc. (—)
CIK:        0001834645
Form:       8-K
Filed at:   2022-11-02T23:59:59+00:00
Accession:  0001193125-22-275470
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 3.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Peak Bio completes SPAC merger; receives Nasdaq delisting notice for low public float
--------------------------------------------------------------------------------

- Completed business combination with Ignyte; common stock to trade as PKBO, warrants as PKBOW on Nasdaq from Nov 2, 2022.
- Nasdaq notified company it fails to meet 1,000,000 unrestricted publicly held shares requirement; suspension set for Nov 10 unless hearing requested.
- Entered new PIPE subscription agreements raising $3.025M from 302,500 shares and 281,325 warrants; also converted $1.75M in bridge loans into 176,579 shares and 164,218 warrants.
- Waived closing conditions requiring $7.5M minimum cash and $20M total cash; Chardan withdrew as financial advisor and forfeited $550k fee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834645/000119312522275470/0001193125-22-275470-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834645/000119312522275470/d391470d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-275470

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer